Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01071369 · ClinicalTrials.gov registry record · Phase 4
Treatment of Chronic Thoracic and Neck and Upper Extremity Pain
A Phase 4 study, sponsored by Pain Management Center of Paducah.
- Completed
- Registry status
- Phase 4
- Development phase
- 120
- Enrollment target
NCT01071369: Completed Phase 4 study, sponsored by Pain Management Center of Paducah.
NCT01071369 is a Phase 4 study that has completed, run by Pain Management Center of Paducah. The registered enrollment target is 120 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01071369, a Phase 4 study, has completed, sponsored by Pain Management Center of Paducah.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 120 participants
- Enrollment target
Study Summary
To study improvements or lack thereof with the interlaminar epidural patients with or without steroids experiences mid back, upper back or neck pain with or without chest wall and upper extremity pain of at least 6-months duration non-responsive to conservative management.
Primary Outcome
examined improvements between those who received and did not receive steroids
Interventions
- DRUG Xylocaine
- DRUG Xylocaine and Celestone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2008-02 |
| Est. Completion | 2012-06 |
| Phase | Phase 4 |
What the finished NCT01071369 record still lists
NCT01071369 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 2 interventions - of which Xylocaine is the first listed.
NCT01071369 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01071369 about?
NCT01071369 is a clinical study titled "Treatment of Chronic Thoracic and Neck and Upper Extremity Pain". To study improvements or lack thereof with the interlaminar epidural patients with or without steroids experiences mid back, upper back or neck pain with or without chest wall and upper extremity pain of at least 6-months duration non-responsive to conservative management.
What is the current status of trial NCT01071369?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 120 participants. The study started on 2008-02. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01071369?
The interventions under investigation include: Xylocaine (DRUG), Xylocaine and Celestone (DRUG).
Who is sponsoring clinical trial NCT01071369?
This trial is sponsored by Pain Management Center of Paducah, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01071369's enrollment target sits among peer trials
120 673rd of 2000 higher than 1,289 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia